Skip to main content
SpringerLink
Log in

Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to analyze the value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin (RISA) in patients treated with hyper-thermic isolated limb perfusion with tumor necrosis factor-α (TNFα) and melphalan.

Methods

Forty-eight patients with melanoma (n=14) or soft tissue sarcoma (n=34) of an extremity underwent 51 perfusions. Perfusion was performed at the iliac level in 22 cases, at the popliteal level in 16 cases, at the femoral level in 7 cases, and at the axillary level in 6 cases. Leakage rates and perfusion circuit and systemic levels of TNFα, interleukin-6, and C-reactive protein were determined, as were systemic hematological and metabolic profiles and tumor response.

Results

The mean isotopically measured leakage was 2.9%. Systemic leakage was ≤2% in 28 perfusions and >2% in 23 perfusions. The correlation between the maximal monitored leakage and maximal systemic TNFα levels was. 7114. The area under the curve for TNFα in the perfusion circuit, indicating the exposure of the perfused limb to TNFα, was 18.7% lower in the >2% leakage group. No significant differences in tumor response were found between groups. The area under the curve for systemic TNFα, indicating the exposure of the patient to TNFα, was 18.1 times higher in the >2% leakage group, resulting in a significant decrease in leukocyte and platelet count, hyperbilirubinemia, hypocholesterolemia, and proteinemia. No beneficial effect of the systemically leaked TNF and melphalan was seen on the occurrence of distant metastasis during follow-up. There was a significant difference between perfusions performed at the iliac and femoral levels compared with leakage values at the popliteal level.

Conclusions

A good correlation between RISA leakage measurement and TNFα exposure during and after hyperthermic isolated limb perfusion with TNFα and melphalan was demonstrated. RISA leakage measurement serves as a good guide for the effectiveness of isolation during perfusion. If leakage exceeds the 2% limit during perfusion, less exposure of the tumor-bearing limb to TNFα, increased exposure of the patient systemic circulation to TNFα, and more systemic side effects can be expected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Creech O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extra-corporeal circuit.Ann Surg 1958; 148: 616–32.

    Article  PubMed  Google Scholar 

  2. Stehlin JS. Hyperthermic perfusion with chemotherapy for cancers of the extremities.Surg Gynecol Obstet 1969; 129: 305–8.

    PubMed  Google Scholar 

  3. Schraffordt Koops H, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III tria.. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.J Clin Oncol 1998; 16: 2906–12.

    Google Scholar 

  4. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.J Clin Oncol 1992; 10: 52–60.

    PubMed  CAS  Google Scholar 

  5. Eggermont AMM, Schraffordt Koops H, Lienard D, et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.J Clin Oncol 1996; 14: 2653–65.

    PubMed  CAS  Google Scholar 

  6. Gerain J, Lienard D, Ewalenko P, Lejeune FJ. High serum levels of TNF-alpha after its administration for isolation perfusion of the limb.Cytokine 1992; 4: 585–91.

    Article  PubMed  CAS  Google Scholar 

  7. Eggimann P, Chiolero R, Chassot PG, Lienard D, Gerain J, Lejeune FJ. Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs.Chest 1995; 107: 1074–82.

    PubMed  CAS  Google Scholar 

  8. Stehlin JS, Clark RL, White EC, Healey JE, Dewey WC, Beerstecher S. The leakage factor in regional perfusion with chemotherapeutic agents.A M A Arch Surg 1960; 80: 934–45.

    Google Scholar 

  9. Alexander C, Omlor G, Berberich R, Gross G, Feifel G. Rapid measurement of blood leakage during regional chemotherapy.Eur J Nucl Med 1993; 20: 187–91.

    Article  PubMed  CAS  Google Scholar 

  10. Hafstrom L, Hugander A, Jonsson PE, Westling H, Ehrsson H. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.Cancer Treat Rep 1984; 68: 867–72.

    PubMed  CAS  Google Scholar 

  11. Stehlin JS, Clark RL, Dewey WC. Continuous monitoring of leakage during regional perfusion.Arch Surg 1961; 83: 943–50.

    PubMed  Google Scholar 

  12. Ghussen F, Nagel K, Sturz I, Isselhard W. A modified dye dilution method to estimate leakage during regional isolated perfusion of the extremity.Res Exp Med (Berl) 1982: 180: 179–87.

    Article  CAS  Google Scholar 

  13. Sardi A, Minton JP, Mojzisik C, et al. The use of a hand-held gamma detector improves the safety of isolated limb perfusion.J Surg Oncol 1989; 41: 172–6.

    Article  PubMed  CAS  Google Scholar 

  14. Sandrock D, Horst F, Gatzemeier W, et al. Leakage measurement during selective limb perfusion using a gamma probe.Eur J Nucl Med 1996; 23: 534–8.

    Article  PubMed  CAS  Google Scholar 

  15. Schraffordt Koops H, Oldhoff J, Oosterhuis JW, Beekhuis H. Isolated regional perfusion in malignant melanoma of the extremities.World J Surg 1987; 11: 527–33.

    Article  PubMed  CAS  Google Scholar 

  16. Fontijne WP, Mook PH, Schraffordt Koops H, Oldhoff J, Wildevuur CR. Improved tissue perfusion during pressure regulated regional perfusion: a clinical study.Cancer 1985; 55: 1455–61.

    Article  PubMed  CAS  Google Scholar 

  17. Wieberdink J, Benckhuysen C, Braat RP, Van Slooten EA, Olthuis GAA. Dosimetry in isolation perfusion of the limb by assessment of perfused tissue volume and grading of toxic tissue reactions.Eur J Cancer Clin Oncol 1982; 18: 905–10.

    Article  PubMed  CAS  Google Scholar 

  18. Schraffordt Koops H. Prevention of neural and muscular lesions during hyperthermic regional perfusion.Surg Gynecol Obstet 1972; 135: 401–3.

    PubMed  CAS  Google Scholar 

  19. Maring JK, Klompmaker IJ, Zwaveling JH, van Der M, Limburg PC, Slooff MJ. Edotoxins and cytokines during liver transplantation: changes in plasma levels and effects on clinical outcome.Liver Transpl 2000; 6: 480–8.

    Article  PubMed  CAS  Google Scholar 

  20. World Health Organization.Handbook for Reporing Results of Cancer Treatment.WHO Offset Publication No. 48, Geneva: World Health Organization, 1979.

    Google Scholar 

  21. Kaplan EL, Meier P. Nonparametric estimates from incomplete observations.J Am Stat Assoc 1958; 53: 457–81.

    Article  Google Scholar 

  22. Stam TC, Swaak AJ, de Vries MR, ten Hagen TL, Eggermont AM. Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage.Ann Surg Oncol 2000; 7: 268–75.

    Article  PubMed  CAS  Google Scholar 

  23. Klaase JM, Kroon BB, Van Geel AN, Eggermont AMM, Franklin HR. Systemic leakage during isolated limb perfusion for melanoma.Br J Surg 1993; 80: 1124–6.

    Article  PubMed  CAS  Google Scholar 

  24. Thom AK, Alexander HR, Andrich MP, Barker WC, Rosenberg SA, Fraker DL. Cytokine levels and and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.J Clin Oncol 1995; 13: 264–73.

    PubMed  CAS  Google Scholar 

  25. Sorkin P, Abu Abid S, Lev D, et al. Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment.Arch Surg 1995; 130: 1079–84.

    PubMed  CAS  Google Scholar 

  26. Vrouenraets BC, Kroon BB, Ogilvie AC, et al. Absence of severe systemic toxicity after, leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan.Ann Surg Oncol 1999; 6: 405–12.

    Article  PubMed  CAS  Google Scholar 

  27. Barker WC, Andrich MP, Alexander HR, Fraker DL. Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs.Eur J Nucl Med 1995; 22: 1242–8.

    Article  PubMed  CAS  Google Scholar 

  28. Zwaveling JH, Maring JK, Clarke FL, et al. High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.Crit Care Med 1996; 24: 765–70.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, 9700 RB, Groningen, the Netherlands

    Robert J. van Ginkel MD, Heimen Schraffordt Koops MD, PhD & Harald J. Hoekstra MD, PhD

  2. Department of Internal Medicine, Groningen Univeristy Hospital, Groninger, the Netherlands

    Pieter C. Limburg PhD

  3. Department of Nuclear Medicine, Groningen University Hospital, Groningen, the Netherlands

    D. Albertus Piers MD, PhD

Authors
  1. Robert J. van Ginkel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pieter C. Limburg PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Albertus Piers MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heimen Schraffordt Koops MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harald J. Hoekstra MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harald J. Hoekstra MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Ginkel, R.J., Limburg, P.C., Piers, D.A. et al. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan. Annals of Surgical Oncology 9, 355–363 (2002). https://doi.org/10.1007/BF02573870

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02573870

Key Words

Search

Navigation